{"DataElement":{"publicId":"3116943","version":"1","preferredName":"Gynecologic Tumor Grouping FIGO 2009 Cervical Carcinoma Stage","preferredDefinition":"the extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body according to the International Federation of Gynecology and Obstetrics Gynecologic (FIGO) 2009 staging system for cervical cancer.","longName":"2190067v1.0:3116923v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2190067","version":"1","preferredName":"Gynecologic Tumor Grouping","preferredDefinition":"information related to gynecologic tumor grouping.","longName":"GYN_TUMOR_GP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177523","version":"1","preferredName":"Grouping","preferredDefinition":"Grouping; a system for classifying things into groups; the activity of putting things together in groups.","longName":"Grouping","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Grouping","conceptCode":"C25523","definition":"A system for classifying things into groups or the activity of putting things together in groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5204-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67FFEA3-D68C-2C1F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3116923","version":"1","preferredName":"FIGO 2009 Cervical Carcinoma Stage","preferredDefinition":"the extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body according to the International Federation of Gynecology and Obstetrics Gynecologic (FIGO) 2009 staging system for cervical cancer.","longName":"3116923v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV","ValueMeaning":{"publicId":"3116926","version":"1","preferredName":"Stage IV","longName":"3116926","preferredDefinition":"The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. A bullous edema, as such, does not permit a case to be allotted to Stage IV (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8160-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8178-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB","ValueMeaning":{"publicId":"3116924","version":"1","preferredName":"Stage IVB","longName":"3116924","preferredDefinition":"Spread to distant organs (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-811A-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8132-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA","ValueMeaning":{"publicId":"3116925","version":"1","preferredName":"Stage IVA","longName":"3116925","preferredDefinition":"Spread of the growth to adjacent organs (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-813D-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8155-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB","ValueMeaning":{"publicId":"3116927","version":"1","preferredName":"Stage IIIB","longName":"3116927","preferredDefinition":"Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8183-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-819B-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA","ValueMeaning":{"publicId":"3116928","version":"1","preferredName":"Stage IIIA","longName":"3116928","preferredDefinition":"Tumor involves lower third of the vagina, with no extension to the pelvic wall (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-81A6-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-81BE-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III","ValueMeaning":{"publicId":"3116929","version":"1","preferredName":"Stage III","longName":"3116929","preferredDefinition":"The tumor extends to the pelvic wall and/or involves lower third of the vagina and/or causes hydronephrosis or non-functioning kidney (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-81C9-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-81E1-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB","ValueMeaning":{"publicId":"3116930","version":"1","preferredName":"Stage IIB","longName":"3116930","preferredDefinition":"With obvious parametrial invasion (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-81EC-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8204-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIA2","valueDescription":"Stage IIA2","ValueMeaning":{"publicId":"3116931","version":"1","preferredName":"Stage IIA2","longName":"3116931","preferredDefinition":"Clinically visible lesion >4 cm in greatest dimension  (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-820F-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8228-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIA1","valueDescription":"Stage IIA1","ValueMeaning":{"publicId":"3116932","version":"1","preferredName":"Stage IIA1","longName":"3116932","preferredDefinition":"Clinically visible lesion =<4.0 cm in greatest dimension (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8232-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-824B-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA","ValueMeaning":{"publicId":"3116933","version":"1","preferredName":"Stage IIA","longName":"3116933","preferredDefinition":"Without parametrial invasion (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8255-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-826D-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II","ValueMeaning":{"publicId":"3116934","version":"1","preferredName":"Stage II","longName":"3116934","preferredDefinition":"Cervical carcinoma invades beyond the uterus, but not to the pelvic wall or to the lower third of the vagina (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8278-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8290-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IB2","valueDescription":"Stage IB2","ValueMeaning":{"publicId":"3116935","version":"1","preferredName":"Stage IB2","longName":"3116935","preferredDefinition":"Clinically visible lesion >4.0 cm in greatest dimension (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-829B-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-82B4-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IB1","valueDescription":"Stage IB1","ValueMeaning":{"publicId":"3116936","version":"1","preferredName":"Stage IB1","longName":"3116936","preferredDefinition":"Clinically visible lesion =<4.0 cm in greatest dimension (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-82BE-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-82D7-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB","ValueMeaning":{"publicId":"3116937","version":"1","preferredName":"Stage IB","longName":"3116937","preferredDefinition":"Clinically visible lesions limited to the cervix uteri or pre-clinical cancers greater than stage IA (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-82E1-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-82F9-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IA2","valueDescription":"Stage IA2","ValueMeaning":{"publicId":"3116938","version":"1","preferredName":"Stage IA2","longName":"3116938","preferredDefinition":"Measured stromal invasion of >3.0 mm and not >5.0 mm with an extension of not >7.0 mm (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8304-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-831D-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IA1","valueDescription":"Stage IA1","ValueMeaning":{"publicId":"3116939","version":"1","preferredName":"Stage IA1","longName":"3116939","preferredDefinition":"Measured stromal invasion of =<3.0 mm in depth and extension of =<7.0 mm (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8327-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8340-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA","ValueMeaning":{"publicId":"3116940","version":"1","preferredName":"Stage IA","longName":"3116940","preferredDefinition":"Invasive carcinoma which can be diagnosed only by microscopy, with\r\ndeepest invasion =<5 mm and largest extension =>7 mm (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-834A-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8362-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I","ValueMeaning":{"publicId":"3116941","version":"1","preferredName":"Stage I","longName":"3116941","preferredDefinition":"The carcinoma is strictly confined to the cervix (extension to the corpus would be disregarded) (according to FIGO 2009 Stage Description)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-836D-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A61BA1F-8385-9CF1-E040-BB89AD43013F","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A61BA1F-8104-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"ALAIS","dateModified":"2010-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434438","version":"1","longName":"Cervical","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"},{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"2190067v1.0:3116923v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Stage","type":"Preferred Question Text","description":"Stage","url":null,"context":"CTEP"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"8A61BA1F-8390-9CF1-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-02","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}